// App-Quantinova.ai

TCT-469 : Frequency, Timing and Implications of Reinfarction after Primary Stenting in ST-Segment Elevation Myocardial Infarction: The HORIZONS-AMI trial

Researchers

Presenter

  • Samantha Stone

Principal Investigators

  • Roxana Mehran

  • Bernhard Witzenbichler

  • Giulio Guagliumi

  • Jan Peruga

  • Bruce Brodie

  • Dariusz Dudek

  • Martin Mockel

  • Gregg Stone

Medical Centers

  • Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY

  • Charite Campus Benjamin Franklin, Berlin, Germany.

  • Charite, Campus Virchow, Berlin, Germany

  • The University Hospital, Krakow, Poland

  • Ospedali Riuniti di Bergamo, Bergamo, Italy

  • LeBauer CV Research Foundation, Greensboro, NC

  • Cardiovascular Research Foundation, Orangeburg, NY

Locations

  • United States

  • Germany

  • Italy

  • Poland

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Myocardial infarction

  • Multi-vessel disease

  • Venous thrombosis

Biomarkers

  • Glycosylphosphatidylinositol

Drug/Treatment

  • Bivalirudin

  • Paclitaxel

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved